Načítá se...
Precision medicine in lupus nephritis: can biomarkers get us there?
Patients with systemic lupus erythematosus (SLE) frequently develop lupus nephritis (LN), a condition that can lead to end stage kidney disease (ESKD). Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of...
Uloženo v:
| Vydáno v: | Transl Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415919/ https://ncbi.nlm.nih.gov/pubmed/30179587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2018.08.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|